ARTL News and Press, Artelo Biosciences Inc. From 01/08/21

Lion Group Holding (LGHL) +142%.SCWorx (WORX) +55%.Future FinTech Group (FTFT) +41%.Optical Cable Corporation (OCC) +29%.ZW Data Action Technologies (CNET) +29%.Jaguar Health (JAGX) +25%.Merus N.V. (MRUS) +24% after FDA grants Fast Track designation to it's Zenocutuzumab.Ideanomics ...

Are These On Your List Of Penny Stocks To Buy Right Now? One of the things we’ve discussed when it comes to penny stocks is price. Obviously, we’re talking about stocks under $5 overall. But the lower the price, typically, the higher the volatility and quicker the ...

LA JOLLA, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the H.C. Wainwright Bi...

Cheap Stocks Under $1 Trending In Final Days Of 2020 One of the fastest-growing trading apps for penny stocks in 2020 was Robinhood. By several accounts, the mobile-first app corralled millions upon millions of new day traders this year. Known for its gamified setup and user-fri...

Artelo Biosciences (ARTL) files a composition of matter patent application directed to a new solid dosage formulation, including its method of use, with the UK Patent Office.This formulation is related to the company’s lead clinical program, ART27.13.ART27.13 is a G...

LA JOLLA, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ) , a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, tod...

LA JOLLA, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ) , a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today a...

LA JOLLA, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ) , a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today&#...

LA JOLLA, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today reported that i...

The Medicines and Healthcare products Regulatory Agency ((MHRA)) has signed-off the Phase 1/2 trial in the U.K. evaluating Artelo Biosciences' ([[ARTL]] +5.7%) ART27.13, synthetic cannabinoid, in patients with cancer anorexia and weight loss. Enrollment expected to initiate before year e...